Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-04-13

Clinical Trial Update: A Study for Subjects With Prostate Cancer Who Previously Participated in an Enzalutamide Clinical Study [Phase 2]

View source ↗

Summary

Phase 2 clinical trial for prostate cancer patients who previously participated in an enzalutamide study; the study is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Enzalutamide (enzalutamide)

Snippet

Sponsor: Astellas Pharma Global Development, Inc. | Conditions: Prostate Cancer | Phase 2 | Status: RECRUITING